Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glutamine and acute illness.

Jan Wernerman1

  • 1Department of Anesthesiology and Intensive Care, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden. jan.werneman@hs.se

Current Opinion in Critical Care
|July 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Net albumin leakage in patients in the ICU with suspected sepsis. A prospective analysis using mass balance calculations.

Critical care (London, England)·2025
Same author

Albumin and fibrinogen synthesis rates in advanced chronic liver disease.

American journal of physiology. Gastrointestinal and liver physiology·2023
Same author

Fibrinogen and albumin synthesis rates in major upper abdominal surgery.

PloS one·2022
Same author

Variability in Skeletal Muscle Protein Synthesis Rates in Critically Ill Patients.

Nutrients·2022
Same author

A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice.

Critical care (London, England)·2021
Same author

Enteral nutrition and dynamics of citrulline and intestinal fatty acid-binding protein in adult ICU patients.

Clinical nutrition ESPEN·2021
Same journal

Cardiogenic shock - toward phenotype-directed, precision management.

Current opinion in critical care·2026
Same journal

The future of critical care nutrition: from calorie counting to precision personalized metabolism therapy.

Current opinion in critical care·2026
Same journal

Editorial introduction.

Current opinion in critical care·2026
Same journal

Generative artificial intelligence for outcome prediction in critical care: the future is now?

Current opinion in critical care·2026
Same journal

Feeding under support in critical care illness: metabolic and nutritional management during extracorporeal membrane oxygenation and continuous renal replacement therapy.

Current opinion in critical care·2026
Same journal

Multinational collaborations in critical care research: feasible and useful?

Current opinion in critical care·2026
See all related articles

This review highlights recent research on glutamine in clinical nutrition. Plasma glutamine levels may serve as a prognostic marker and guide glutamine supplementation in intensive care unit patients.

Area of Science:

  • Clinical Nutrition
  • Biochemistry

Background:

  • Glutamine is an amino acid with crucial roles in cellular metabolism and immune function.
  • Its significance in clinical nutrition is increasingly recognized, prompting extensive research.

Purpose of the Study:

  • To review recent literature (past 2 years) on glutamine's role in clinical nutrition.
  • To highlight experimental findings and focus on clinical applications.
  • To assess the potential of plasma glutamine as a prognostic marker in intensive care.

Main Methods:

  • Systematic literature review of studies published within the last two years.
  • Analysis of experimental and clinical studies focusing on glutamine metabolism and supplementation.
  • Evaluation of research investigating plasma glutamine levels in intensive care unit (ICU) settings.

Related Experiment Videos

Main Results:

  • Recent literature confirms glutamine's diverse roles in various experimental models.
  • Clinical studies emphasize glutamine's impact on patient outcomes.
  • Plasma glutamine concentration at ICU admission emerged as a potential prognostic indicator.

Conclusions:

  • Plasma glutamine levels show promise as a biomarker for critically ill patients.
  • This marker may help guide the decision for glutamine supplementation in intensive care.
  • Further research is warranted to validate these findings and optimize clinical protocols.